Rapid influenza testing with Cepheid XPert Flu in Emergency Department Practice
NIH/NIAID, FDA/CDER and BARDA coordinate efforts to improve endpoints for clinical trials with new antivirals.
Using endpoints originally established for clinical efficacy with oseltamivir has forced manufacturers to engage outpatient locations for enrollment of individuals with influenza-like-illness in large numbers, with very few individuals having complicated influenza that would benefit from antiviral treatment.
The PHEMCE coordination has the goal to improve enrollment of high risk individuals such as those who present to the JHU Emergency Department, are identified as influenza virus positive by advanced rapid diagnostic testing, many of which are subsequently hospitalized.
These patients can be treated early; thus providing a target population that can be more effectively monitored for clinical response to treatment.
Using endpoints originally established for clinical efficacy with oseltamivir has forced manufacturers to engage outpatient locations for enrollment of individuals with influenza-like-illness in large numbers, with very few individuals having complicated influenza that would benefit from antiviral treatment.
The PHEMCE coordination has the goal to improve enrollment of high risk individuals such as those who present to the JHU Emergency Department, are identified as influenza virus positive by advanced rapid diagnostic testing, many of which are subsequently hospitalized.
These patients can be treated early; thus providing a target population that can be more effectively monitored for clinical response to treatment.
Related Programs
Biomedical Advanced Research and Development Authority (BARDA), Biodefense Medical Countermeasure De
Department of Health and Human Services
Agency: Department of Health and Human Services
Office: HHS - Office of the Secretary
Estimated Funding: Not Available
Office: HHS - Office of the Secretary
Estimated Funding: Not Available
Obtain Full Opportunity Text:
Rapid influenza testing with Cepheid XPert Flu in Emergency Department Practice
Additional Information of Eligibility:
John Hopkins University, School of Medicine
Full Opportunity Web Address:
https://www.grantsolutions.gov/gs/preaward/previewPublicAnnouncement.do?id=49817
Contact:
Grants.gov Contact CenterPhone Number: 1-800-518-4726Hours of operation are 24 hours a day, 7 days a week. The contact center is closed on federal holidays.support@grants.gov
Agency Email Description:
Grants.gov Customer Support
Agency Email:
support@grants.gov
Date Posted:
2014-09-19
Application Due Date:
2014-09-24
Archive Date:
2014-10-24
Social Entrepreneurship
Spotlight
Rwanda as Social Entrepreneur Fund Beneficiary
The Republic of Rwanda has been picked as one of the six African countries as beneficiaries for a new fellowship fund program designed at supporting social entrepreneurs in tackling issues on food security.
Learn How to Identify and Avoid Grant Scams
